Basilea Pharmaceutica Investor Relations Material
Latest events
H2 2024
Basilea Pharmaceutica
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Basilea Pharmaceutica AG
Access all reports
Basilea Pharmaceutica AG is a biopharmaceutical company specializing in the research, development, and commercialization of hospital anti-infectives and oncology medicines. It focuses on therapies addressing antimicrobial resistance and cancer. The company is headquartered in Basel, Switzerland, and its shares are listed on the SIX Swiss Exchange.
Key slides for Basilea Pharmaceutica AG
H2 2024
Basilea Pharmaceutica AG
H1 2024
Basilea Pharmaceutica AG
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
BSLN
Country
🇨🇭 Switzerland